Terms: = Lymphoma AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
630 results:
1. Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.
Hao Z; Fei Y; Chen J; Huang S; Wang L; Yu Y; Bian M; Si Y; Zhang X; Yang X; Zhang B; Wan Y; Zhang Y; Lin G
Hematology; 2024 Dec; 29(1):2344998. PubMed ID: 38666535
[TBL] [Abstract] [Full Text] [Related]
2. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.
Brigitha LJ; Mondelaers V; Liu Y; Albertsen BK; Zalewska-Szewczyk B; Rizzari C; Kotecha RS; Pieters R; Huitema ADR; van der Sluis IM
Pharm Res; 2024 Apr; 41(4):711-720. PubMed ID: 38538970
[TBL] [Abstract] [Full Text] [Related]
4. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Kater AP; Arslan Ö; Demirkan F; Herishanu Y; Ferhanoglu B; Diaz MG; Leber B; Montillo M; Panayiotidis P; Rossi D; Skarbnik A; Tempescul A; Turgut M; Mellink CH; van der Kevie-Kersemaekers AF; Lanham S; Sale B; Del Rio L; Popovic R; Chyla BJ; Busman T; Komlosi V; Wang X; Sail K; Pena GE; Vizkelety T; Forconi F
Lancet Oncol; 2024 Apr; 25(4):463-473. PubMed ID: 38467131
[TBL] [Abstract] [Full Text] [Related]
5. Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia.
Gharial J; Guilcher G; Truong T; Shah R; Desai S; Rojas-Vasquez M; Kangarloo B; Lewis V
Pediatr Blood Cancer; 2024 Apr; 71(4):e30844. PubMed ID: 38217082
[TBL] [Abstract] [Full Text] [Related]
6. Maintenance therapy for chronic lymphocytic leukaemia.
Lee CH; Wu YY; Huang TC; Lin C; Zou YF; Cheng JC; Chen PH; Jhou HJ; Ho CL
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013474. PubMed ID: 38174814
[TBL] [Abstract] [Full Text] [Related]
7. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
[TBL] [Abstract] [Full Text] [Related]
8. Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Zeidan AM; Ando K; Rauzy O; Turgut M; Wang MC; Cairoli R; Hou HA; Kwong YL; Arnan M; Meers S; Pullarkat V; Santini V; Malek K; Kiertsman F; Niolat J; Ramos PM; Menssen HD; Fenaux P; Miyazaki Y; Platzbecker U
Lancet Haematol; 2024 Jan; 11(1):e38-e50. PubMed ID: 38065203
[TBL] [Abstract] [Full Text] [Related]
9. Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell lymphoma : A Cost-Effectiveness Analysis.
Kelkar AH; Cliff ERS; Jacobson CA; Abel GA; Dijk SW; Krijkamp EM; Redd R; Zurko JC; Hamadani M; Hunink MGM; Cutler C
Ann Intern Med; 2023 Dec; 176(12):1625-1637. PubMed ID: 38048587
[TBL] [Abstract] [Full Text] [Related]
10. Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States.
Phillips T; Liu N; Bloudek B; Migliaccio-Walle K; Reynolds J; Burke JM
J Manag Care Spec Pharm; 2023 Dec; 29(12):1312-1320. PubMed ID: 37921077
[TBL] [Abstract] [Full Text] [Related]
11. Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20
Munoz J; Flinn IW; Cohen JB; Sachs J; Exter B; Ranger A; Harris P; Payumo F; Nath R; Hamadani M; Westin JR; Bachanova V
Transplant Cell Ther; 2024 Feb; 30(2):241.e1-241.e8. PubMed ID: 37898374
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical efficacy and safety of venetoclax combined with multidrug chemotherapy in the treatment of 15 patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia].
Kong JY; Zong LH; Pu Y; Liu Y; Kong X; Li MY; Zhang J; Song BQ; Xue SL; Tang XW; Qiu HY; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):649-653. PubMed ID: 37803838
[No Abstract] [Full Text] [Related]
13. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle.
Zhuang X; Liu B; Long J; Wang H; Yu J; Ji X; Li J; Zhu N; Li L; Chen Y; Liu Z; Zhao S
Clin Transl Oncol; 2024 Apr; 26(4):936-950. PubMed ID: 37783922
[TBL] [Abstract] [Full Text] [Related]
14. Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study.
Nguyen PT; Hori M; Matsuda T; Katanoda K
Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1756-1770. PubMed ID: 37756571
[TBL] [Abstract] [Full Text] [Related]
15. Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
Nastoupil LJ; Hess G; Pavlovsky MA; Danielewicz I; Freeman J; García-Sancho AM; Glazunova V; Grigg A; Hou JZ; Janssens A; Kim SJ; Masliak Z; McKay P; Merli F; Munakata W; Nagai H; Özcan M; Preis M; Wang T; Rowe M; Tamegnon M; Qin R; Henninger T; Curtis M; Caces DB; Thieblemont C; Salles G
Blood Adv; 2023 Nov; 7(22):7141-7150. PubMed ID: 37722354
[TBL] [Abstract] [Full Text] [Related]
16. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract] [Full Text] [Related]
17. Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open-label, phase I study in healthy subjects.
Tachibana M; Matsuki S; Maekawa Y; Kuroda K; Shimizu T; Tsutsumi J; Ishizuka H
Clin Transl Sci; 2023 Nov; 16(11):2153-2162. PubMed ID: 37705321
[TBL] [Abstract] [Full Text] [Related]
18. Rates and predictors of visits to primary care physicians during and after treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
Breakey VR; Sutradhar R; Nathan PC; Patel S; Wheaton L; Li Q; Bassal M; Gibson P; Pole JD; Athale U; Gupta S
Pediatr Blood Cancer; 2023 Oct; 70(10):e30610. PubMed ID: 37534917
[TBL] [Abstract] [Full Text] [Related]
19. Eyewash with balanced salt solution after intravitreal methotrexate injection in a case of vitreoretinal lymphoma: a simple but effective way to prevent ocular surface toxicity.
Moharana B; Parija S; Palanisamy S; Mishra P
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474142
[TBL] [Abstract] [Full Text] [Related]
20. Childhood and Adolescent Cancer Care at a Tertiary Hospital in Northern Tanzania: A Retrospective Study.
Majaliwa E; Smith ER; Cotache-Condor C; Rice H; Gwanika Y; Canick J; Chao N; Schroeder K; Rice HE; Staton C; Mmbaga BT
JCO Glob Oncol; 2023 Jun; 9():e2200263. PubMed ID: 37384861
[TBL] [Abstract] [Full Text] [Related]
[Next]
